192TiP: NEPTUNE: A global, phase 3 study of durvalumab (MEDI4736) plus tremelimumab combination therapy versus standard of care (SoC) platinum-based chemotherapy in the first-line treatment of patients (pts) with advanced or metastatic NSCLC
Mok, T., Schmid, P., Arén, O., Arrieta, O., Gottfried, M., Jazieh, A.R., Ramlau, R., Timcheva, K., Martin, C., McIntosh, S.Volume:
11
Langue:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/S1556-0864(16)30301-X
Date:
April, 2016
Fichier:
PDF, 80 KB
english, 2016
File converter
Plus de résultats de recherche
More benefits 
